Thompson, Andrew E <br/><br/>
Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials.  [electronic resource] 

 -  Arthritis and rheumatism  Jun 2011 
 - 1479-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1529-0131 
<br/><br/><label>Standard No.: </label>10.1002/art.30310  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--drug therapy<br/>Communicable Diseases--epidemiology<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Male<br/>Methotrexate--adverse effects<br/>Middle Aged<br/>Neoplasms--chemically induced<br/>Randomized Controlled Trials as Topic<br/>Risk<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors